Literature DB >> 28926440

Epidural Labor Analgesia-Fentanyl Dose and Breastfeeding Success: A Randomized Clinical Trial.

Amy I Lee1, Robert J McCarthy, Paloma Toledo, Mary Jane Jones, Nancy White, Cynthia A Wong.   

Abstract

BACKGROUND: Breastfeeding is an important public health concern. High cumulative doses of epidural fentanyl administered for labor analgesia have been reported to be associated with early termination of breastfeeding. We tested the hypothesis that breastfeeding success is adversely influenced by the cumulative epidural fentanyl dose administered for labor analgesia.
METHODS: The study was a randomized, double-blind, controlled trial of parous women at greater than 38 weeks gestation who planned to breastfeed, had successfully breastfed a prior infant, and who received neuraxial labor analgesia. Participants were randomized to receive one of three epidural maintenance solutions for labor analgesia (bupivacaine 1 mg/ml, bupivacaine 0.8 mg/ml with fentanyl 1 μg/ml, or bupivacaine 0.625 mg/ml with fentanyl 2 μg/ml). The primary outcome was the proportion of women breastfeeding at 6 weeks postpartum. Maternal and umbilical venous blood fentanyl and bupivacaine concentration at delivery were measured.
RESULTS: A total of 345 women were randomized and 305 had complete data for analysis. The frequency of breastfeeding at 6 weeks was 97, 98, and 94% in the groups receiving epidural fentanyl 0, 1, and 2 μg/ml, respectively (P = 0.34). The cumulative fentanyl dose (difference: 37 μg [95% CI of the difference, -58 to 79 μg], P = 0.28) and maternal and umbilical cord venous fentanyl and bupivacaine concentrations did not differ between women who discontinued breastfeeding and those who were still breastfeeding at 6 weeks postpartum.
CONCLUSIONS: Labor epidural solutions containing fentanyl concentrations as high as 2 μg/ml do not appear to influence breastfeeding rates at 6 weeks postpartum.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28926440     DOI: 10.1097/ALN.0000000000001793

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

Review 1.  A Review of the Impact of Obstetric Anesthesia on Maternal and Neonatal Outcomes.

Authors:  Grace Lim; Francesca L Facco; Naveen Nathan; Jonathan H Waters; Cynthia A Wong; Holger K Eltzschig
Journal:  Anesthesiology       Date:  2018-07       Impact factor: 7.892

Review 2.  Neuraxial techniques of labour analgesia.

Authors:  Sunanda Gupta; Seema Partani
Journal:  Indian J Anaesth       Date:  2018-09

3.  A priori choice of neuraxial labour analgesia and breastfeeding initiation success: a community-based cohort study in an Italian baby-friendly hospital.

Authors:  Roberto Giorgio Wetzl; Enrica Delfino; Luca Peano; Daniela Gogna; Yvette Vidi; Francesca Vielmi; Eleonora Bianquin; Serena Cerioli; Maria Enrica Bettinelli; Maria Lorella Giannì; Gabriella Frassy; Elena Boris; Cesare Arioni
Journal:  BMJ Open       Date:  2019-03-05       Impact factor: 2.692

4.  Comparison of the Analgesic Effect of Ropivacaine with Fentanyl and Ropivacaine Alone in Continuous Epidural Infusion for Acute Herpes Zoster Management: A Retrospective Study.

Authors:  Hee Yong Kang; Chung Hun Lee; Sang Sik Choi; Mi Kyoung Lee; Yeon Joo Lee; Jong Sun Park
Journal:  Medicina (Kaunas)       Date:  2020-01-08       Impact factor: 2.430

5.  Determination of the Dose-Response Relationship of Epidural Dexmedetomidine Combined with Ropivacaine for Labor Analgesia.

Authors:  Zhong Mei; Jing Yu; Jian-Xin Ni; Jia-Li Feng; Sheng-Jie Yao; Li-Feng Ni; Shao-Bo Song; Cong-Zhong Song; Xiao-Wei Qian
Journal:  Drug Des Devel Ther       Date:  2022-03-06       Impact factor: 4.162

6.  Comparison of ropivacaine combined with sufentanil for epidural anesthesia and spinal-epidural anesthesia in labor analgesia.

Authors:  Yanshuang Wang; Mingjun Xu
Journal:  BMC Anesthesiol       Date:  2020-01-02       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.